Onchocerciasis

(redirected from blinding disease)
Also found in: Dictionary, Thesaurus, Medical.

onchocerciasis

[‚äŋ·kō·sər′kī·ə·səs]
(medicine)
Infection with the filaria Onchocerca volvulus ; results in skin tumors, papular dermatitis, and ocular complications.

Onchocerciasis

 

a chronic parasitic disease that is caused by nematodes of the genus Onchocerca. Onchocerciasis occurs universally and mainly affects ungulates; the greatest economic damage arises when cattle and horses are affected. The intermediate hosts of Onchocerca are simuliids and ceratopogonids, which are bloodsucking insects. The infestation is most prevalent in pastures during the swarming time of the intermediate hosts. The mature parasites concentrate in the tendons, ligaments, and connective tissue, causing inflammatory foci that are often aggravated by pyogenic microflora.

Onchocerciasis usually occurs without observable symptoms. Diagnosis in the living animal is based on the presence of Onchocerca larvae in skin biopsies and on the results of allergic skin tests. No specific treatment is available. Onchocerciasis is prevented by protecting animals from the bites of simuliids and ceratopogonids and by exterminating these insects during hatching time, from May to August.

REFERENCE

Skriabin, K. I., and A. M. Petrov. Osnovy veterinarnoi nematodologii. Moscow, 1964.
References in periodicals archive ?
The blinding disease results from mutations in the gene RPE65, which encodes a protein that helps rod cells in the eye recycle light-gathering pigments.
Narfstrom is involved primarily with Abyssinian and Persian cats that are affected with hereditary retinal blinding disease. The cat's eye is a good model to use for this type of research because it is very similar to a human eye in size and construction, so surgeons can utilize the same techniques and equipment.
"I believe that with its unique drug-delivery technology Retisert will offer an efficacious treatment for this chronic, severe blinding disease," says Glenn Jaffe, professor of ophthalmology and director of the Uveitis Service at Duke University Eye Center in Durham, N.C.
Eliminating trachoma as a blinding disease is the goal of the Alliance for the Global Elimination of Trachoma by 2020.
AMD is a blinding disease that affects the eye's light-sensitive cells (photoreceptors).
They began by researching the very mechanisms of this blinding disease, then working to find a product that would treat one of the primary factors associated with it: elevated intraocular pressure."
AMD is a common blinding disease where central vision is irreversibly lost and affects one in three people in their 80s.
Like dry AMD, there is no treatment available for this blinding disease.
Keratoconus is a potentially blinding disease, for which no therapeutic treatment is available in the US Recently, the Eye Bank Association of America noted that over 6,800 corneal transplants were performed annually in patients diagnosed with keratoconus.
Once this has happened, the visual damage is permanent, which is why glaucoma is described as the "silent blinding disease" or the "sneak thief of sight".
Unfortunately, we are not very accurate at predicting which babies will get it, so have to screen many children to pick up the few with blinding disease.
Keratoconus is a potentially blinding disease, for which limited therapeutic treatment is available in the US Recently, the Eye Bank Association of America noted that over 6,800 corneal transplants were performed annually in patients diagnosed with keratoconus.